[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fdZ1ACnRRKnS3zrGgjbwXH-Q6yeKW71v15Hh8JfaEmVY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":33,"rows":40},"Cordis US Corp.",[4],78,false,3,21,87928,0,77,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Coronary Artery Disease",36,{"name":18,"count":19},"Abdominal Aortic Aneurysm",4,{"name":21,"count":8},"Carotid Artery Disease",{"name":23,"count":8},"Coronary Disease",{"name":25,"count":8},"Angioplasty, Transluminal, Percutaneous Coronary",{"name":27,"count":8},"Coronary Arteriosclerosis",{"name":29,"count":8},"Peripheral Artery Disease",{"name":31,"count":8},"Arterial Occlusive Diseases",[],[34,35,36,37,38,39],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[41],{"intervention":42,"totalTrials":43,"cells":44},"Clopidogrel & Aspirin, Prasugrel & Aspirin",1,{"EARLY_PHASE1":45,"PHASE1":47,"PHASE2":49,"PHASE3":51,"PHASE4":53,"NA":66},{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[55],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":65},"NCT00954707","CYPRESS - CYPHER for Evaluating Sustained Safety","UNKNOWN",[38],"2012-01","2016-03","2009-08",2509,[15],[42],{"trials":67,"activeCount":11},[]]